Central role for interleukin-2 in type 1 diabetes |
| |
Authors: | Hulme Maigan A Wasserfall Clive H Atkinson Mark A Brusko Todd M |
| |
Institution: | Department of Pathology, University of Florida, Gainesville, Florida, USA. |
| |
Abstract: | Type 1 diabetes presents clinically with overt hyperglycemia resulting from progressive immune-mediated destruction of pancreatic β-cells and associated metabolic dysfunction. Combined genetic and immunological studies now highlight deficiencies in both the interleukin-2 (IL-2) receptor and its downstream signaling pathway as a central defect in the pathogenesis of type 1 diabetes. Prior intervention studies in animal models indicate that augmenting IL-2 signaling can prevent and reverse disease, with protection conferred primarily by restoration of regulatory T-cell (Treg) function. In this article, we will focus on studies of type 1 diabetes noting deficient IL-2 signaling and build what we believe forms the molecular framework for their contribution to the disease. This activity results in the identification of a series of potentially novel therapeutic targets that could restore proper immune regulation in type 1 diabetes by augmenting the IL-2 pathway. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|